Wikisage, the free encyclopedia of the second generation, is digital heritage
Lorazepam: Difference between revisions
Jump to navigation
Jump to search
(type) |
m (→clonazepam) |
||
| Line 15: | Line 15: | ||
[[Midazolam]] (or lorazepam i.v.) controls effectively 63-73% early SE<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/pdf/40265_2015_Article_454.pdf Pharmacotherapy for Status Epilepticus]</ref> | [[Midazolam]] (or lorazepam i.v.) controls effectively 63-73% early SE<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/pdf/40265_2015_Article_454.pdf Pharmacotherapy for Status Epilepticus]</ref> | ||
==clonazepam== | ==clonazepam== | ||
[[clonazepam]] is more lipophylic that lorazepam, but less lipophilic than diazepam(Congdon et Forsythe | [[clonazepam]] is more lipophylic that lorazepam, but less lipophilic than [[diazepam]] (Congdon et Forsythe (1980) Epilepsia 21:97) | ||
==[[Levetiracetam|Levetirazetam]]== | ==[[Levetiracetam|Levetirazetam]]== | ||
Revision as of 22:48, 27 January 2016
sufficient lengh of time (viewed as 30 min.period)
Status epilepticus, ILAE view as a seizure that persists for a sufficient lengh of time, maybe 5-10 (focal) minutes.
[1]
diazepam
intravenous
Other agents
lorazepam>phenitoin
midazolam
Midazolam (or lorazepam i.v.) controls effectively 63-73% early SE[2]
clonazepam
clonazepam is more lipophylic that lorazepam, but less lipophilic than diazepam (Congdon et Forsythe (1980) Epilepsia 21:97)
Levetirazetam
comparison
Propofol
recruitment problem
see also Trinka et al 2015 Pharmacotherapy for Status Epilepticus Drugs 1491-1521.
